WX Downgraded To Neutral At Goldman

by Monica Gerson, Benzinga Staff Writer
May 14, 2010 6:53 AM | 9 seconds read |
Analysts at Goldman Sachs downgrade WuXi PharmaTech WX from "buy" to "neutral." WX dipped 0.48% to close at $18.81 yesterday. More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: EarningsDowngradesMarketsAnalyst RatingsTrading IdeasGoldmanHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!